Combined17a-hydroxylase/17,20-lyase deficiency is a rare cause of congenital adrenal hyperplasia and hypogonadism. Hypertension and hypokalemia are essential presenting features. We report an Arab family with four affected XX siblings. The eldest presented with abdominal pain and was diagnosed with a retroperitoneal malignant mixed germ cell tumour. She was hypertensive and hypogonadal. One sibling presented with headache due to hypertension while the other two siblings were diagnosed with hypertension on a routine school check. A homozygous R96Q missense mutation in P450c17 was detected in the index case who had primary amenorrhea and lack of secondary sexual characters at 17 years. The middle two siblings were identical twins and had no secondary sexual characters at the age of 14. All siblings had hypokalemia, very low level of adrenal androgens, high ACTH and high levels of aldosterone substrates. Treatment was commenced with steroid replacement and puberty induction with estradiol. The index case had surgical tumor resection and chemotherapy. All siblings required antihypertensive treatment and the oldest remained on two antihypertensive medications 12 years after diagnosis. Her breast development remained poor despite adequate hormonal replacement. Combined 17a-hydroxylase/17,20-lyase deficiency is a rare condition but might be underdiagnosed. It should be considered in young patients presenting with hypertension, particularly if there is a family history of consanguinity and with more than one affected sibling. Antihypertensive medication might continue to be required despite adequate steroid replacement. Breast development may remain poor in mutations causing complete form of the disease.
Biglieri in 1966 (2) when he reported a patient presenting with features of hypogonadism, hypocortisolism and hypertension.
The gene encoding P450c17 (10q24.3) was cloned in 1987. It encodes eight exons over 6.4 kbDNA (3) . Mutation in the gene was first reported in 1988 (4) . Since then, various mutations have been described, including single amino acid changes (5) . A multicentre study group from Brazil reported seven novel mutations in 19 Brazilian kindred with 17 hydroxylase deficiency. Point mutations were the most common form of genetic defect in this cohort (6) . Genotype phenotype correlation was variable amongst different ethnic groups. In a Japanese cohort, the correlation was also well-established as it was in the Chinese population (7) . Initial presentation can be variable based on the gene defect. Dhir et al. reported two 46 XY patients presenting with hypertension and short stature and another 46,XX patient in whom primary amenorrhea was the initial presenting feature (8) .
Data on this rare condition from the Arab world is sparse despite the high consanguinity rate in the region. This might be due to the condition being underdiagnosed, in addition to being rare. The first case described in the region was a 22-year-old Omani patient who was confirmed to have c.287GOA p.Arg96Gln P450c17-homozygous mutation resulting in the complete absence of 17a-hydroxylase/17/20-lyase activity (9) . We describe a family of four affected siblings from the United Arab Emirates in whom age at presentation and presenting features were variable.
Case presentation
The affected patients are four sisters born to first degree related parents (Fig. 1) . The index case (patient 1) is an XX female who presented with a malignant mixed germ cell tumour with yolk sac elements. At the age of 17, she had no secondary sexual characters and had primary amenorrhea. She had palmer pigmentation and her initial blood pressure was 170/96 (5).
Patient 2 is a 14 year old (twin 1) who was referred from school after a routine health check when she was found to have a high blood pressure of 163/117. Clinically, she had no secondary sexual characteristics and normal external female genitalia. Both her height and weight were at the 3rd percentile.
Patient 3 is twin 2 (identical). She presented with a headache for 6 months prior to hospital referral. Her blood pressure on presentation was 155/110. Clinically, she was pre-pubertal with normal growth parameters.
Patient 4 is an 8-year-old girl who was referred from school following a routine health check. Her blood pressure was 153/85 (above 97th percentile for age) but she was asymptomatic. Clinically, she was pre-pubertal and had normal female external genitalia. Her height and weight were at the 50th percentile.
Patients 2, 3 and 4 were diagnosed eight and nine years following the diagnosis of the index case respectively. At the time of the index case diagnosis, no siblings were screened for the genetic mutation, neither were they followed up for blood pressure monitoring. The older siblings, 23 and 26 years, have given birth to children. The 18-year-old sibling entered puberty at 12 and currently has a regular period and the youngest 7 year old is growing normally and has a normal blood pressure.
Investigation
Index case: She was hypokalemic with a serum potassium of 2.5 mmol (NR 4.0 to 4.8) and high gonadotropin levels. Serum aldosterone was high at 643 pmol/l (NR 55 to 250) and plasma renin was undetectable as were her serum dehydroepiandrostendione sulphate, 17 hydroxy progesterone and testosterone. Serum cortisol was decreased at 15 nmol/l at 0900 h with a concurrent ACTH level of 21 mcg/l (NR 3 to 11). Serum a fetoprotein was elevated at 12 714 mU/l. Retroperitoneal mass was diagnosed on computerized axial tomography scanning. Histopathology showed malignant mixed germ cell tumor with yolk sac components. The gonads had the macroscopical appearance of ovaries but were not biopsied. Adrenal ultrasonography showed bilateral adrenal hyperplasia. Mutation analysis revealed a homozygous R96Q missense mutation in P450c17. 
Outcome and follow-up
Index case: She had no recurrence of the tumor for 17 years post-surgery and chemotherapy. Her hypertension remained difficult to control and she needed combined antihypertensive treatment of spironolactone 50 mg and amlodipine 5 mg daily. She has regular withdrawal bleeds on cyclical combined pills and remained compliant of prednisolone. Her breast development is poor and is currently considering breast augmentation. Patients 2 and 3: Both girls remained on antihypertensive medication (spironolactone 25 mg daily) to The compliance issue was strictly monitored on the 4 siblings through steroid medications refill monitoring and was confirmed biochemically by normalization of the ACTH in all of the siblings.
Discussion
Hypertension and hypokalemia are essential features in combined 17a-hydroxylase/17,20-lyase deficiency. However, it is noted that the age at the onset of hypertension and the degree of hypokalemia vary even within the same mutation (1). In addition, the presentation of the condition varies with 15% of patients being normokalemic and normotensive at diagnosis (1). Our four patients were hypertensive at diagnosis, although in the index case hypertension was not the presenting feature of the disease. Only one sibling presented with symptomatic hypertension. The other two were found to be hypertensive on routine school check while the index case was diagnosed with hypertension during her work up for the presenting germ cell tumor. The youngest was 8 years old when she presented with symptomatic hypertension. To the best of our knowledge, she is the youngest patient reported in the literature to present with hypertension due to this mutation. Mula-Abdel reported a case of 17a-hydroxylase/17,20-lyase deficiency who presented at 10 years old with hypertension and was treated with antihypertension medication until the age of 22 when the diagnosis was confirmed (9) . This highlights the importance of considering this disease in the differential diagnoses of hypertension in children and adolescents which might be underdiagnosed.
The index case presented with a mixed germ cell tumor. This is likely to be a chance association with the P450c17 mutation. A gonadoblastoma has been reported in a 17-year-old 46,XX Brazilian patient with combined 17a-hydroxylase/17,20-lyase deficiency (6) .
The R96Q mutation in this family resulted in a complete absence of 17a-hydroxylase/17/20-lyase activity (5). Our index case was reported in 2006 when the mutation (R96Q) was novel. In 2013, Athanasoulia reported the same mutation in another patient who showed breast tissue unresponsiveness despite estradiol treatment (10) . This phenomenon was attributed to the high progesterone levels pre-diagnosis having an irreversible effect on breast tissue. This feature was observed in our eldest patient who remained at breast stage II-III, despite adequate estradiol replacement and is currently considering breast augmentation surgery. Compliance with steroid replacement is crucial for correction of hypokalemia and treatment of the hypertension. Adherence to appropriate oestradiol regime ensures progression to puberty. In this family, compliance in the four siblings has been monitored carefully and is believed to be good on the basis of uptake of medication in each case and normalisation of ACTH on therapy. Accordingly, we speculate that this particular mutation has a specific adverse effect on puberty progression particularly on breast development.
Endocrine causes for hypertension should be considered in children and adolescents presenting with high blood pressure. Thorough history and clinical exam is essential to make the diagnosis of this rare condition. In addition, hypertension is an important sign in patients with primary amenorrhea as it should point attention to adrenal disorder.
Conclusion
P450c17 mutation is rare but an important cause of hypertension. Rare forms of congenital adrenal hyperplasia should be considered in presence of hypertension, particularly if more than one sibling is affected. Antihypertensive medications might be required along with appropriate steroid replacement.
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